Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a paper by Charlie Hamm et al. published in JAMA Oncology:
“Can biopsy be omitted after a negative MRI in suspected prostate cancer?
- In a 3-year study of 593 men, 48% had negative MRI results – 86% avoided biopsy.
- Only 4% of those monitored developed clinically significant prostate cancer.
- MRI has high negative predictive value, making biopsy omission safe with proper monitoring!”
“Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer”
Authors: Charlie Hamm, Patrick Asbach, Anna Pöhlmann, Frank König, Hannes Cash et al.
More posts featuring Yüksel Ürün.